- Report
- July 2026
- 180 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- September 2025
Global
From €4351EUR$4,900USD£3,731GBP
- Report
- August 2026
- 384 Pages
Global
From €5194EUR$5,850USD£4,455GBP
- Report
- June 2026
- 120 Pages
Global
From €4218EUR$4,750USD£3,617GBP
- Report
- June 2026
- 255 Pages
Global
From €4258EUR$4,795USD£3,652GBP
- Report
- June 2026
- 100 Pages
Africa, Middle East
From €3370EUR$3,795USD£2,890GBP
- Report
- June 2026
United States
From €2220EUR$2,500USD£1,904GBP
- Report
- August 2025
- 191 Pages
Global
From €3148EUR$3,545USD£2,700GBP
€3498EUR$3,939USD£3,000GBP
- Report
- March 2024
- 200 Pages
Global
From €3685EUR$4,150USD£3,160GBP
- Report
- March 2024
- 120 Pages
Global
From €3996EUR$4,500USD£3,427GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1776EUR$2,000USD£1,523GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1110EUR$1,250USD£952GBP
- Report
- April 2023
- 147 Pages
Global
From €4394EUR$4,949USD£3,769GBP
- Report
- May 2024
- 128 Pages
Global
From €2663EUR$2,999USD£2,284GBP
€3551EUR$3,999USD£3,045GBP
- Report
- June 2026
- 100 Pages
South Africa, Russia, ... South Africa, Russia, India, China, Brazil
From €3370EUR$3,795USD£2,890GBP
- Report
- June 2026
United Kingdom
From €2220EUR$2,500USD£1,904GBP
From €2220EUR$2,500USD£1,904GBP
- Report
- June 2026
South Korea
From €2220EUR$2,500USD£1,904GBP
- Report
- June 2026
Saudi Arabia
From €2220EUR$2,500USD£1,904GBP
From €2220EUR$2,500USD£1,904GBP

Valganciclovir is an antiviral drug used to treat infections caused by certain viruses, such as cytomegalovirus (CMV). It is used in the treatment of infectious diseases, including CMV retinitis, a viral infection of the retina that can cause blindness. Valganciclovir is also used to prevent CMV infection in people who have received organ transplants. It works by blocking the action of the virus in the body, preventing it from multiplying and spreading.
Valganciclovir is available in tablet and oral solution form. It is usually taken twice daily, with or without food. Common side effects include nausea, vomiting, diarrhea, and headache. More serious side effects may include kidney problems, anemia, and low white blood cell count.
Valganciclovir is marketed by several pharmaceutical companies, including Genentech, Merck, and Novartis. It is also available as a generic drug. Show Less Read more